Physician profile
Bernardo Tan
NPI 1790742047
$2,549.30
in general payments reported to CMS, 2019-2025
22 companies · $419 in 2025
The $419 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $302 · 2021: $486 · 2022: $266 · 2023: $298 · 2024: $255 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $972.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $351.26 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $308.40 | 2019 | |
| Supernus Pharmaceuticals, INC. | $279.91 | 2021-2025 | Qelbree |
| Cranial Technologies, INC | $217.17 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $208.99 | 2019-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Sanofi Pasteur INC. | $196.98 | 2019-2025 | |
| Pfizer INC. | $184.18 | 2021-2024 | |
| Ironshore Pharmaceuticals INC. | $152.22 | 2019-2023 | Jornay Pm |
| Glaxosmithkline, LLC. | $142.27 | 2019-2025 | Bexsero, Pediarix, Penmenvy |
| Collegium Pharmaceutical, INC. | $89.31 | 2025 | Jornay Pm |
| Covidien LP | $86.85 | 2020 | |
| Electromed, INC. | $50.84 | 2021-2024 | Smartvest |
| Lnhc, INC | $45.23 | 2025 | Zelsuvmi |
| Kowa Pharmaceuticals America, INC. | $42.81 | 2021-2025 | Zoryve |
| Ultragenyx Pharmaceutical INC. | $33.74 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $33.04 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.93 | 2023 | Flumist Quadrivalent |
| Takeda Pharmaceuticals U.S.A., INC. | $22.66 | 2024 | |
| Qol Medical, LLC | $22.30 | 2022 | |
| Corium, LLC | $19.66 | 2022 | |
| Chiesi USA, INC. | $18.90 | 2024 | Lamzede |
| Baxter Healthcare | $18.65 | 2025 | Hillrom - Vest System Model 105 Home Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernardo Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.